Capricor Therapeutics (CAPR)
(Delayed Data from NSDQ)
$5.33 USD
+0.13 (2.50%)
Updated May 15, 2024 04:00 PM ET
After-Market: $5.35 +0.02 (0.38%) 5:52 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-0.32 | 0.00% |
Earnings Summary
For their last quarter, Capricor Therapeutics (CAPR) reported earnings of -$0.31 per share, missing the Zacks Consensus Estimate of -$0.11 per share. This reflects a negative earnings surprise of 181.82%. Look out for CAPR's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$0.32 per share, reflecting a year-over-year decrease of 10.34%.
Earnings History
Price & Consensus
Zacks News for CAPR
Verano Holdings Corp. (VRNOF) Reports Q1 Loss, Tops Revenue Estimates
CAPR: What are Zacks experts saying now?
Zacks Private Portfolio Services